Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
Rosen Law Firm is notifying investors in Avis Budget Group (CAR) and Park Ha Biological Technology (PHH, BYAH) about ongoing securities class action lawsuits. The Avis lawsuit alleges that Pentwater Capital Management LP and its CEO orchestrated a market manipulation scheme involving aggressive stock purchases that triggered a short squeeze, artificially inflating stock prices. Investors with losses exceeding $100,000 are encouraged to join the class action before the September 29, 2026 deadline.
09/06/2026, 6:13 PM • GlobeNewswire
Rosen Law Firm reminds investors of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) of the September 28, 2026 lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that defendants made materially false statements and failed to disclose that Park Ha was subject to a fraudulent stock promotion scheme involving social media misinformation, artificially low public float, and manipulated trading activity.
09/06/2026, 5:35 PM • GlobeNewswire
Rosen Law Firm reminds investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) who purchased securities between December 27, 2024 and July 8, 2025 of the September 28, 2026 deadline to become lead plaintiffs in an ongoing securities class action. The lawsuit alleges the company made false statements and failed to disclose involvement in stock manipulation schemes, artificially low public float during IPO, and misleading positive statements about business operations.
09/06/2026, 5:35 PM • GlobeNewswire
A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and structured its IPO with an artificially low public float to facilitate manipulation. Investors who purchased Park Ha securities between December 27, 2024 and July 8, 2025 are eligible to join the case, with a lead plaintiff deadline of September 21, 2026.
09/06/2026, 12:00 PM • GlobeNewswire
Rosen Law Firm has filed securities class actions against multiple companies, including Wise Group plc (WSE), alleging false and misleading statements regarding regulatory compliance and anti-money laundering efforts. Investors with losses exceeding $100K are encouraged to join the class action before the September 29, 2026 deadline.
09/03/2026, 8:21 PM • GlobeNewswire
Rosen Law Firm is seeking lead plaintiffs for securities class action lawsuits against Park Ha Biological Technology Co., Ltd. and other companies. The firm alleges that Park Ha made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, artificially low public float, and manipulated trading activity during the class period of December 27, 2024 to July 8, 2025. The lead plaintiff deadline is September 28, 2026.
08/31/2026, 10:01 PM • GlobeNewswire
A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased securities between December 27, 2024 and July 8, 2025 are encouraged to join the case, with a lead plaintiff deadline of September 21, 2026.
08/30/2026, 12:00 PM • GlobeNewswire
A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased Park Ha securities between December 27, 2024 and July 8, 2025 are eligible to join the case, with a lead plaintiff deadline of September 21, 2026.
08/26/2026, 12:00 PM • GlobeNewswire
Rosen Law Firm has filed a class action lawsuit on behalf of investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) for the period between December 27, 2024 and July 8, 2025. The lawsuit alleges that defendants made materially false statements and failed to disclose that Park Ha was subject to a fraudulent stock promotion scheme involving social media misinformation, impersonated financial professionals, and artificially manipulated trading activity. The firm is seeking investors who purchased securities during the class period to join the action, with a lead plaintiff deadline of September 28, 2026.
08/07/2026, 6:37 PM • GlobeNewswire
Rosen Law Firm has filed class action lawsuits against Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) on behalf of investors who purchased securities between December 27, 2024 and July 8, 2025. The lawsuit alleges that defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, artificially low public float, and manipulated trading activity. The deadline to serve as lead plaintiff is September 28, 2026.
08/04/2026, 8:19 PM • GlobeNewswire
Rosen Law Firm has filed class action lawsuits against Park Ha Biological Technology Co., Ltd. (PHH, BYAH) for securities fraud involving false statements and undisclosed fraudulent stock promotion schemes during December 2024-July 2025. A separate lawsuit targets GRAIL, Inc. (GRAL) with an August 4, 2026 deadline for investors to secure counsel. Both cases allege material misstatements and failure to disclose adverse facts affecting stock prices.
08/01/2026, 2:58 PM • GlobeNewswire
Robbins LLP announces a securities class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) for allegedly being subject to a market manipulation and pump-and-dump scheme involving social media misinformation and impersonated financial professionals. The company failed to disclose material risks associated with the scheme. Park Ha's stock surged from $4.00 to $41.49 before collapsing 93% to $2.99 on July 8, 2025, wiping out over $1 billion in market value. The lead plaintiff deadline is September 28, 2026.
07/31/2026, 8:23 PM • GlobeNewswire
A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased securities between December 27, 2024 and July 8, 2025 can join the case, with a lead plaintiff deadline of September 21, 2026.
07/30/2026, 12:36 PM • GlobeNewswire
Park Ha Biological Technology (BYAH) Stock Surges Over 41% After Hours: Why Is It Moving?
Park Ha Biological Technology (NASDAQ: BYAH) shares jumped 41.66% to $1.70 in after-hours trading following the closing of a $2.0 million registered direct offering. The stock had dropped 20% during regular trading to $1.20. The company also announced a strategic AI-driven skincare partnership with Star Plus Action. Despite the after-hours surge, BYAH has declined 99.89% over the past 12 months and remains near its annual low, indicating continued investor pressure.
06/18/2026, 12:27 AM • Benzinga
Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering
Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) announced a registered direct offering of up to 1,133,332 Class A ordinary shares and pre-funded warrants to purchase 200,000 shares at $1.50 per unit, expected to raise approximately $2.0 million. The offering is expected to close on June 15, 2026, with net proceeds designated for general corporate and working capital purposes. D. Boral Capital LLC is serving as the sole placement agent.
06/12/2026, 2:54 PM • GlobeNewswire
